Literature DB >> 4053007

Uptake of hematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature, and cell size.

R M Böhmer, G Morstyn.   

Abstract

Normal and malignant cells were incubated with hematoporphyrin derivative (HPD) and their uptake and retention of HPD were analyzed by flow cytometry. In standard growth medium the amount of HPD taken up by cells was proportional to the added HPD concentration and reached a plateau level after 5-6 h of incubation. The uptake occurred in two steps; within seconds a large amount of HPD became loosely bound to the cells, presumably the outer membrane. This was followed by a slower uptake of HPD into the cytoplasm. The loosely bound portion could be washed from the cells by medium containing either fetal calf serum or serum albumin. At low temperatures the uptake into the cytoplasm was strongly reduced. A major determinant of HPD uptake was the concentration of serum in the medium. At any particular concentration of HPD below 200 mg/liter, increasing concentrations of fetal calf serum or bovine serum albumin resulted in a reduction in the amount of HPD taken up by cells. A further factor affecting uptake was the pH of the medium. At low pH (pH 6) the rate of HPD incorporation was much higher than at pH 7.4. Under identical conditions of incubation, HPD uptake was proportional to cell size as estimated using the low angle light scatter signal in the flow cytometer. Our data suggest that acidic pH, differences in extracellular serum concentrations of malignant tumor tissue, as well as the increased size of tumor cells may play an important role in the selective uptake of HPD by malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053007

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Texaphyrins: tumor localizing redox active expanded porphyrins.

Authors:  Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

3.  pH effect on cellular uptake of Sn(IV) chlorine e6 dichloride trisodium salt by cancer cells in vitro.

Authors:  Khaled A Al-Khaza'leh; Khalid Omar; M S Jaafar
Journal:  J Biol Phys       Date:  2010-10-30       Impact factor: 1.365

4.  Photo-immunotargeting with haematoporphyrin conjugates activated by a low-power He-Ne laser.

Authors:  T Berki; P Németh
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Hematoporphyrin derivative and anthracyclines mutually inhibit cellular uptake and toxicity.

Authors:  R M Böhmer; K Hoffmann; G Morstyn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells.

Authors:  Xin Chen; Li Hui; David A Foster; Charles Michael Drain
Journal:  Biochemistry       Date:  2004-08-31       Impact factor: 3.162

7.  Phototherapy of posterior uveal melanomas.

Authors:  I Favilla; W R Barry; A Gosbell; P Ellims; F Burgess
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

8.  The photodynamic effect of methylene blue and toluidine blue on Candida albicans is dependent on medium conditions.

Authors:  Gabriela Guimarães Carvalho; Monalisa Poliana Felipe; Maricilia Silva Costa
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

Review 9.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

10.  In vitro photosensitization of tumour cell enzymes by photofrin II administered in vivo.

Authors:  S L Gibson; R S Murant; M D Chazen; M E Kelly; R Hilf
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.